C. Brekelmans

发表

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

C. Seynaeve, J. Klijn, E. Meijers-Heijboer, 2000, British Journal of Cancer.

Contralateral recurrence and prognostic factors in familial non‐BRCA1/2‐associated breast cancer

C. Seynaeve, M. Menke-Pluymers, A. Eggermont, 2006, The British journal of surgery.

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

P. Devilee, C. Seynaeve, A. Wagner, 2000, The Lancet.

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

J. Klijn, P. Devilee, C. Seynaeve, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The epidemiological profile of women with an interval cancer in the DOM screening programme

P. Peeters, H. Collette, C. Brekelmans, 2004, Breast Cancer Research and Treatment.

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1

J. Klijn, P. Devilee, A. Ouweland, 1998, The Lancet.

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

M. Schutte, R. Tollenaar, P. Devilee, 2004, Journal of Medical Genetics.

Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.

H. Collette, P. Peeters, P. Westers, 1996, Journal of epidemiology and community health.

Breast cancer after a negative screen: follow-up of women participating in the DOM Screening Programme.

C Collette, H. Collette, J. Fracheboud, 1992, European journal of cancer.

Possible consequences of applying guidelines to healthy women with a family history of breast cancer

W. E. Hoogendoorn, R. Tollenaar, P. Devilee, 2003, European Journal of Human Genetics.

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

M. Schutte, R. Tollenaar, P. Devilee, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Survival in interval breast cancer in the DOM screening programme.

H. Collette, P. Peeters, C. Brekelmans, 1995, European Journal of Cancer.

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.

J. Klijn, H. Meijers-Heijboer, C. Seynaeve, 2007, European journal of cancer.

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

J. Klijn, C. Seynaeve, A. V. D. van den Ouweland, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival and prognostic factors in BRCA1-associated breast cancer.

J. Klijn, H. Meijers-Heijboer, C. Seynaeve, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)

C. Boetes, H. D. de Koning, J. Klijn, 2001, Familial Cancer.

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.

J. Klijn, C. Seynaeve, A. V. D. van den Ouweland, 2004, European journal of cancer.

Authors' reply: Contralateral recurrence and prognostic factors in familial non‐BRCA1/2‐associated breast cancer (Br J Surg 2006; 93: 961–968)

M. Tilanus-Linthorst, C. Brekelmans, C. T. M. Brekelmans, 2007 .

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study

H. V. van Boven, C. Brekelmans, R. Verheijen, 2007, British Journal of Cancer.

Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.

E. Berns, C. Seynaeve, C. Brekelmans, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer

J. Klijn, R. Tollenaar, H. Peterse, 2006, Breast Cancer Research and Treatment.